EDTUTC-4 New YorkLog in Sign up

ADIL
Adial Pharmaceuticals, Inc
stockNASDAQ

At CloseOct 27, 2026 2:22:04 PM EDT

3.93USD+6.793%(+0.25)7,357

3.0100Bid4.7100Ask1.7000Spread

ADIL News

Day breaks

08:12 AM EDTAdial Pharmaceuticals to appoint Celia Economides as CFO ·

Seeking Alpha

07:04 AM EDTAdial Pharmaceuticals appoints David Rubenstein as chief scientist ·

Investing.com

07:00 AM EDTAdial Pharmaceuticals Appoints David Rubenstein, M.D., Ph.D., as Chief Scientist to Advance its Colon-Targeted AhR Agonist, AT177, for Ulcerative Colitis ·

GlobeNewswire Inc.

05:46 PM EDTAdial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) ·

GlobeNewswire Inc.